Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
Next Generation of Combination Products: Insights from the FDA Office of Combination Products and Industry Expert Application
Session Chair(s)
James Wabby, MHS
- Global Head, Regulatory Affairs, Emerging Technologies and Combination Products
- AbbVie, Inc., United States
This forum will present FDA regulatory insights and discuss examples of current trends in the space of combination products. A panel of FDA representatives will provide updates on FDA policy and industry experts will share practices on application.
Learning Objective : Discuss and analyze the latest FDA regulatory expectations and challenges; Recognize current topics the FDA is observing and what industry should continue to do and what is causing challenging circumstances.
Speaker(s)
FDA Update
John Barlow Weiner, JD
- Associate Director for Policy, Office of Combination Products, OCPP, OC
- FDA, United States
Panelist
Susan Neadle, MS
- Principal Consultant and President
- Combination Products Consulting Services LLC, United States

Panelist
Kate Gillespie, BSN, MBA
- Senior Director, Global Product Vigilance and Post Market Reporting
- Johnson & Johnson, United States